Butakovskaya N. V., Timofeeva L. M. Medical Application of Shungite in Health Resort “White Springs”, OJSC (OAO). / Materials of the First All-Russian Research and Practical Conference “Shungite and Personal Safety”. Petrozavodsk.: Carbon-Shungite. - 2006. - p. 75-79.
Medical Application of Shungite at the Health Resort “White Springs”, OJSC (OAO)
N. V. Butakovskaya, L. M. Timofeeva
Health Resort “White Springs” (Belye Klyuchi), OAO; Petrozavodsk
The “White Springs” resort ( hereinafter “resort”) has been operating as a general balneotherapeutic health resort for 20 years.
Therapeutic methods used at the resort are identical to those used at the health resort of Martsialnye Vody. Specifically, these are mineral water and muds from Lake Gabozero.
The health resort can accommodate up to 150 people at the same time.
Hydrotherapy with mineral baths, mud therapy, ozone therapy, hirudotherapy, and shungitotherapy are offered at our health resort.
Treatment methods with the use of shungite-based mineral preparations introduced in 2001 include:
- Concentrated shungite water for external use – gargling, inhalation, wrapping;
- Shungite paste for applications;
- Shungite mixture for mineral baths.
As many as 1,510 people have been treated with the use of shungite.
Effect of low-intensity EHF radiation on red bone marrow and blood cells when shielded with shungite
Effect of low-intensity EHF RADIATION on RED BONE MARROW AND BLOOD CELLS when SHIELDED WITH SHUNGITE
A. A. Khadartsev*, A. A. Yashin*
Martsialnye Vody (founded by Peter I) in Karelia and Darasun in Zabaykalsky Krai are the oldest spa towns in Russia. In these two towns healing waters flow along the geological section passing through mineralizing rock masses, specifically shungite in Karelia and zeolite in Zabaykalsky Krai. It should be noted, however, that while in Russia alone there are about a hundred of zeolite deposits, the world’s only shungite deposit is found near Shun’ga, a village in Karelia – hence the name of the mineral.
Thus, people began to use the biotropic healing properties of shungite as many as three centuries ago. However, there has been a growing interest in shungite over the past few years from both a scientific point of view [1, 2] and medical and prophylactic point of view [3, 4]. This has happened due to the discovery of fullerenes, C60 molecules, in shungite [1, 2]. These molecules resemble the ball used in soccer and are very different in their structure from other naturally occurring minerals such as graphite, diamond and carbyne. The discovery of fullerenes was first predicted by D. Bonchar and E. Galperin in 1973 . Later, fullerenes were produced artificially as a new form of carbon sparking a “fullerene boom” in medicine (which is still on!). The spherical structure of fullerene molecules with OH radicals attached makes C60 fullerenes very chemically (biochemically) active what explains their extensive use in modern medicine.
The Ministry of Health of the USSR
The First Leningrad Institute of Medicine of red labor banner named after academician I.P. Pavlov
Leningrad 197089, Lva Tolstogo street 68
The Rector’s telephone number 233 14 71
The Secretary’s telephone number 2337153
At the clinic of Nephrology and Urology of St. Petersburg Medical Institute from September 1 of ' 92 to May 31 of ' 93, was conducted the clinical observation of the patients with kidney disease:
Group of patients with:
- Urolithiasis - 45 people, average age 45 +- 5
- Chronic pyelonephritis – 150 people, average age 48 +- 7
- Chronic glomerulonephritis - 24, mean age 24 +-7
Water purified by shungite was used for cooking, drinks making and herbal teas. Patients received the water during the entire period of hospitalization (20 +-5 days in average), and then at home.
The control group consisted of 43 people, who were on treatment in the hospital № 26 of the city of St. Petersburg, among them Kidney disease - 21 patients, Chronic pyelonephritis – 10 people, Chronic glomerulonephritis – 6 people. The usual tap water was used for drinking. With the use of purified water in all patients noted improvement in general condition, increase of diuresis.
The most pronounced effect was observed in patients with chronic pyelonephritis, whose inflammation and diuresis disorders disappeared much faster, significantly improved overall health. In patients with chronic glomerulonephritis significant changes in the clinical picture and laboratory data were not observed.
In conclusion, it should be noted that the application of shungite water is indicated for patients with kidney disease (urolithiasis, chronic pyelonephritis), both in hospital and in outpatient settings.
To Director Kalinin Y.K.
In February-March of 1998 in the orthopedic Department of the Republican hospital of the Ministry of health of Karelia with the consent of the patients was held the external application of carbon-shungite infusion (CSI) with pH value of 2.8-3.2 m on 12 patients with the following disorders:
Trophic ulcers of the shin – 6 patients
Osteomyelitis of the tibia – 5 patients
Purulent prepatellar bursitis – 1 patient.
The infusion was used in the following ways:
- a)Overlay of impregnated bandage for a day with subsequent replacement
- b)Overlay of impregnated bandages with additional soaking every three hours
- c)Three-hour applique with bandages changes every 30 minutes
- d)Washing of sinus tracts
- e)Washing of purulent boxes around the clock using flow-through aspiration system
The first experience of application of carbon-shungite infusion showed cleansing of wounds and ulcers from fibro–purulent raids, reduction of granulation tissue, and acceleration of marginal epithelization. Applying the method in combination with other therapeutic factors has achieved epithelialization of the ulcer in all patients treated. The erasure of osteomyelitis and purulent discharge reduction were noted. Five-day washing of pouch for purulent prepatellar bursitis in combination with antibiotics and immobilization quickly stopped purulent process and prevented the operation.
First experience of CSI applying gives positive results and confirms the required volume and testing methods with clinical entities expansion.
Deputy Chief Physician of the Republican hospital of surgery
Chief of trauma orthopedist
CONCLUSIVE DECISION concerning application of shungite paste, ointment and suspension for external therapy
Saint Petersburg Medical Institute of
Hygiene and Sanitation
Department of dermatovenereology
(Head of department prof. M.E. Starchenko)
concerning application of shungite paste, ointment and suspension for external therapy
The goal of the present research was effectiveness study of shungite suspension in the form of stupes, shungite paste and ointment using for outward application.
The group of patients (53) who suffered from various forms of allergodermathosis, psoriasis and erythema centrifugum was formed. The biggest group to the number of 23 persons consisted of patients with eczema. Almost all the patients had severe, capricious and torpid progression of the disease in past medical history.
The II study group consisted of patients with atopic dermatosis (neurodermatitis disseminata) to the number of 9 persons. All the patients had severe recurrent progression of the disease with evident severe skin itching. It is really difficult to select an external therapy for such patients because there is intolerance to many medications in this case.
The third study group to the number of 15 persons was composed of patients who suffered from psoriasis exudativa and psoriasis with apparent large infiltrated plaques; three patients suffered from seborrhea congestiva.
There were 53 patients under the care of physicians in total. They were from 18 to 80 years old but the largest group was 30-50 years old. There were 21 females and 32 males among them.
SHUNGITE SUSPENSION was used for patient curing who suffered from severe skin disease process followed by apparent water thesaurismosis, erythema; and some of patients suffered from madescence.
There were 23 patients under observation, 16 persons among them had eczema in the exacerbation phase with apparent microvesiculation; 5 of them had atopic dermatosis (neurodermatitis disseminata); 2 of them had nasty form of madidans psoriasis exudativa. All the patients without any exception complained of severe itching.
Shungite suspension was used in the form of soaking therapy and wet-to-dry dressings at a dilution of 1:3. Dressings were changed 3-4 times throughout the day. All the patients noticed subsidence of itching first and then itching disappearance. Within first 2-3 days stopping of madescence and water thesaurismosis were noticed; alloeosis – 3, mend – 17, without action – 3. Later 20 patients were treated by SHUNGITE PASTE. We used 25% shungite based on zinc paste. There were 32 patients under observation with diagnosis: eczema – 17 persons, atopic dermatosis (neurodermatitis disseminata) – 6, psoriasis – 6, seborrhea congestiva – 3 persons.
7 patients who suffered from eczema had multivalent hypersensitivity to external therapy, intolerance to many medications (wood tar, naphthalan, basic bismuth gallate, boric acid, salicylic acid). Patients with eczema and atopic dermatosis complained of severe itching that remained even under pressure of hyposensitization therapy.
Shungite paste was well tolerated by all the patients. They noticed itching subsidence and then its total disappearance. Erythema, water thesaurismosis disappeared by 5th-7th day of shungite paste using. Patients with eczema had specific impact caused by conducted therapy. Favourable evolution (itching disappearance; flattening of papules, plaques; peeling disappearance) was noticed in psoriasis case. Specific impact was noticed in case of 3 patients with seborrhea congestiva. Erythema and acanthokeratodermia retracted thanks to external therapy conducted in association with constitutional therapy. Alloeosis – 20, mend – 12, without action – non.
25% SHUNGITE OINTMENT (base is petrolate) was used for curing of chronic patients (18), 6 of them had eczema, 3 of them had atopic dermatosis (neurodermatitis disseminata), 9 of them had psoriasis.
There were signs of apparent chronic inflammation (infiltration, fissures) on the skin of the patients. All of them complained of severe itching. During first day 83% of patients didn’t suffer from itching, after 7-10 days infiltration was solved almost completely in patients who had eczema and neurodermia; psoriasis plaques flattened considerably. Alloeosis – 6, mend – 10, without action – 2.
Therefore alloeosis was noticed in 29 patients what is equal to 54,7 % in patient group (53) studied by us. Generally this number included patients who suffered from allergodermathosis (eczema, atopic dermatosis).
Mend was noticed in 19 patients (it was equal to 35,8%). Patients with atopic dermatosis, psoriasis and seborrhea congestiva were included in study group.
Action from conducted therapy didn’t occur in 2 patients with atopic dermatosis which amounted to 9,5%.
Synthesis and analysis of obtained results allows us to arrive at the conclusion that shungite suspension, paste and ointment: 1) are nonhazardous dermatics with apparent antihistaminic and anti-inflammatory action which eliminates itching and skin disorder. 2) don’t have an adverse affect; no complications were noticed during treatment.
Thus obtained results prove effectiveness of shungite suspension, paste and ointment for external therapy of patients suffered from allergodermathosis, psoriasis and seborrhea congestiva. They exhibit apparent anti-inflammatory properties (eliminate itching, inflammation) and could be used for external treatment of patients with skin conditions.
Head of department
prof. Doctor of Medicine Starchenko M.E.
Candidate of Medical Science Piryatinskaya V. A.
Resident Medical Practitioner Lytaeva E. A.